M22H-04

N/A

Report date: 2026/05/12 09:09:42
NME

Base Information

Drug NameM22H-04
Drug Alias NameHPV vaccine (Virogin Biotech Canada)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccineCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionProtein E6 inhibitorsProtein E7 inhibitors
TargetsProtein E7Protein E6
Therapy Area/IndicationsNeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirogin Biotech Canada Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVirogin Biotech Canada Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasmsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A